Inventor · disambiguated record
David Barbie
Also filed as: BARBIE DAVID
5 granted patents·5 pending applications·13 citations·filing 2015–2023
74Inventor score
Files withDANA FARBER CANCER INST INC10
Top patents by PatentIndex Score
10 records- 0187US11098369B2Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture deviceDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 24, 2021·5 cites·19 claims
- 0287US10472599B2Microfluidic cell culture of patient-derived tumor cell spheroidsDANA FARBER CANCER INST INC·Filed 2016·Granted Nov 12, 2019·5 cites·16 claims
- 0386US12116636B2Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture deviceDANA FARBER CANCER INST INC·Filed 2021·Granted Oct 15, 2024·1 cites·24 claims
- 0482US11572590B2Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture deviceDANA FARBER CANCER INST INC·Filed 2018·Granted Feb 7, 2023·2 cites·20 claims
- 0570US2024125787A1Sting levels as a biomarker for cancer immunotherapyDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0666US2020399573A9Microfluidic cell culture of patient-derived tumor cell spheroidsDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0760US11874276B2STING levels as a biomarker for cancer immunotherapyDANA FARBER CANCER INST INC·Filed 2019·Granted Jan 16, 2024·0 cites·17 claims
- 0858US2025295686A1Combination decitabine and mps1 inhibitor therapy to prime cancer immunogenicityDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0948US2022305048A1Use of heparin to promote type 1 interferon signalingDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1033US2017115291A1Activating JAK Kinase Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor ResponseDANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Barbie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →